Container with pillsThe overall goal of the Cancer Therapeutics Program (CTP) is to promote interactions along the continuum of basic, preclinical, and clinical research, to develop innovative approaches to drug treatment of solid tumors and hematologic malignancies.

Specifically, the CTP aims to:

  1. Identify new anticancer agents;
  2. Understand the mechanism(s) of action of new and existing anticancer drugs; and
  3. Optimize schedules and doses of antineoplastic drugs.

Read more about the Cancer Therapeutics Program

See Program Members

Research Themes:

Mechanisms of Action of Anticancer Agents

Investigate molecular mechanisms of novel and existing anticancer therapeutics

Preclinical Drug Discovery and Development

Discover, design, and develop novel anticancer agents and/or combination regimens

Early Phase Clinical Trials

Design and perform Phase I, Phase I/II, and Phase II studies of anticancer therapeutics